pubmed-article:16117698 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0017601 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0028840 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0040233 | lld:lifeskim |
pubmed-article:16117698 | lifeskim:mentions | umls-concept:C0525227 | lld:lifeskim |
pubmed-article:16117698 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16117698 | pubmed:dateCreated | 2005-8-24 | lld:pubmed |
pubmed-article:16117698 | pubmed:abstractText | The aim of this study was to compare the safety and intraocular pressure (IOP)- lowering efficacy of a fixed combination of brimonidine 0.2% and timolol 0.5% (fixed brimonidine/ timolol) versus each drug used as monotherapy. | lld:pubmed |
pubmed-article:16117698 | pubmed:language | eng | lld:pubmed |
pubmed-article:16117698 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16117698 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16117698 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16117698 | pubmed:issn | 1080-7683 | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:WilliamsRober... | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:SchiffmanRhet... | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:WaltersThomas... | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:CheethamJanet... | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:CravenE... | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:ChouConnieC | lld:pubmed |
pubmed-article:16117698 | pubmed:author | pubmed-author:Combigan... | lld:pubmed |
pubmed-article:16117698 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16117698 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:16117698 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16117698 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16117698 | pubmed:pagination | 337-48 | lld:pubmed |
pubmed-article:16117698 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:meshHeading | pubmed-meshheading:16117698... | lld:pubmed |
pubmed-article:16117698 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16117698 | pubmed:articleTitle | Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension. | lld:pubmed |
pubmed-article:16117698 | pubmed:affiliation | Glaucoma Consultants of Colorado, Littleton, CO, USA. ercraven@yahoo.com | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16117698 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16117698 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16117698 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16117698 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16117698 | lld:pubmed |